Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson et al. · New England Journal of Medicine · 2003 · 920 citations · Full text

Medicine, Endocrinology, Genetics +15

Tumor-Induced Osteomalacia

Suzanne M. Jan de Beur · JAMA · 2005 · 251 citations

Medicine, Nephrology, Oncology +17

Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia

Erik A. Imel, Munro Peacock, Pisit Pitukcheewanont et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 227 citations

Medicine, Endocrinology, Pathobiology +15

Exclusion of Chronic Osteomyelitis With F-18 Fluorodeoxyglucose Positron Emission Tomographic Imaging

Hongming Zhuang, Paulo Schiavom Duarte, MICHAEL POURDEHAND et al. · Clinical Nuclear Medicine · 2000 · 195 citations

Medicine, Nuclear Medicine, Radiology +16

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

Clemens Decristoforo, Stephen J. Mather, Witold Cholewiński et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 176 citations

Medicine, Nuclear Medicine, Radiology +17